Arcataur Capital Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Buy
108,125
+4,000
+4% +$101K 0.68% 25
2026
Q1
$2.63M Buy
104,125
+30,840
+42% +$787K 0.73% 24
2025
Q4
$1.87M Sell
73,285
-400
-0.5% -$10.2K 0.54% 28
2025
Q3
$1.89M Hold
73,685
0.55% 28
2025
Q2
$1.86M Buy
73,685
+10,220
+16% +$254K 0.58% 27
2025
Q1
$1.59M Buy
+63,465
New +$1.57M 0.54% 28

Other funds holding IBDX

Arcataur Capital Management's IBDX Position: Q2 2026 in Review

Arcataur Capital Management increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 3.8% in Q2 2026, buying an estimated $101K and bringing the position to 108,125 shares worth $2.72M. The position accounts for 0.68% of the portfolio, ranked #25.

Arcataur Capital Management first reported a position in IBDX in Q1 2025 and has held it in 6 quarters since. 186 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Arcataur Capital Management held 108,125 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.72M as of Q2 2026.
  • Arcataur Capital Management bought 4,000 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $101K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.68% of Arcataur Capital Management's portfolio in Q2 2026, its #25 holding.
  • Arcataur Capital Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
  • 186 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.